How many insider trades does FilingIQ track for TRAW?

FilingIQ tracks 61 Form 4 insider transactions for TRAW (TRAWS PHARMA INC), covering filings from Apr 1, 2024 onwards. 14 of those were filed in the last 90 days.

Are TRAW insiders net buyers or net sellers?

Across the full Form 4 history for TRAW, 4 transactions (7%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TRAW insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TRAW in?

TRAWS PHARMA INC (TRAW) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $13.40M.

TRAW insider trading

NasdaqCM Healthcare

TRAWS PHARMA INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

7% / 0%

Market cap

$13.40M

About TRAWS PHARMA INC

Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are designed to address treatment resistance, such as TRX01 (Ratutrelvir), an inhibitor in development for the treatment of COVID-19; and Tivoxavir marboxil, an endonuclease inhibitor in development for the treatment of bird flu and seasonal influenza. It is also developing narazaciclib, a multi-targeted kinase inhibitor in solid tumors and hematological malignancies as a single agent or in combination with other anti-cancer therapies; and rigosertib, which is administered alone or in combination for investigation in various cancers. It has a license agreement with SymBio Pharmaceuticals Limited, Pint International SA, Viriom, Inc., and Temple University. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.

Company website: www.trawspharma.com

TRAW insider activity at a glance

FilingIQ has scored 61 insider transactions for TRAW since Apr 1, 2024. The most recent filing in our index is dated Apr 16, 2026.

Across the full history, 4 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TRAW insider trades is 68.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TRAW trades on FilingIQ

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for TRAW?: FilingIQ tracks 61 Form 4 insider transactions for TRAW (TRAWS PHARMA INC), covering filings from Apr 1, 2024 onwards. 14 of those were filed in the last 90 days.
Are TRAW insiders net buyers or net sellers?: Across the full Form 4 history for TRAW, 4 transactions (7%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TRAW insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TRAW in?: TRAWS PHARMA INC (TRAW) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $13.40M.

Methodology & sources

Every TRAW insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.